In medical news:

Coventry recently announced the release of the third part of its 2016 Drug Trends Series, which is based on all calendar year transactions billed through its PBM Program, First Script, as well as transactions from medical bill review to reflect the total pharmacy experience for their client base. This third piece in the series focuses on opioids and compound drugs.

Read more and download here.

Leave a Comment

Your email address will not be published. Required fields are marked *